-
April 27, 2022 Lupin and Yabao Announce Strategic Partnership in China
-
April 18, 2022 Lupin Receives Tentative Approval from U.S. FDA for Tenofovir Alafenamide Tablets
-
April 14, 2022 Lupin Receives Approval from U.S. FDA for Desvenlafaxine Extended-Release Tablets 25 mg
-
April 7, 2022 Lupin Launches Merzee® Capsules in the United States
-
April 7, 2022 Lupin Completes Acquisition of Brands from Anglo-French
-
April 5, 2022 Lupin Enters into Licensing Agreement with Alvion to market Cardiometabolic Drugs in the Southeast Asia region
-
March 24, 2022 Lupin Receives Approval from U.S. FDA for Sildenafil for Oral Suspension
-
March 11, 2022 Lupin Receives Approval from U.S. FDA for Vigabatrin for Oral Solution USP
-
March 10, 2022 Lupin Launches its First Reference Laboratory in East India Establishing its Diagnostics Business in Kolkata
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications